Combination chemotherapy for a senile patient with adenoid cystic carcinoma of the esophagus: a case report.

Abstract

Adenoid cystic carcinoma of the esophagus with multiple liver metastases was found in a 77-year-old Japanese female in October, 1991. Combination chemotherapy, including etoposide (VP-16) and tegafur (FT) allowed the patient to survive for approximately a year after the onset of the initial symptoms. During her course of treatment, the patient improved greatly with minimal toxicity, and declines in the elevated levels of GOT and LDH were also noted. Since no other therapy, such as surgery or radiation, was given to the patient, the response to chemotherapy as well as the survival advantage for the patient have been evaluated.

• Authors: M Matsumoto, T Nomiyama, J Nakae, H Nishikawa
• Journal: Japanese journal of clinical oncology (Jpn J Clin Oncol) Vol. 23 Issue 4 Pg. 258-62 (Aug 1993) ISSN: 0368-2811 [Print] England
• PMID: 8411740 (Publication Type: Case Reports, Journal Article)

Chemical References

• Tegafur
• Etoposide

Topics

• Aged
• Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
• Carcinoma, Adenoid Cystic (diagnostic imaging, drug therapy, pathology, secondary)
• Esophageal Neoplasms (diagnostic imaging, drug therapy, pathology)
• Esophagoscopy
• Esophagus (diagnostic imaging)
• Etoposide (administration & dosage)
• Female
• Humans
• Liver Neoplasms (secondary)
• Tegafur (administration & dosage)
• Tomography, X-Ray Computed